nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
2022: a banner year for systemic lupus erythematosus?
|
The Lancet Rheumatology, |
|
|
4 |
7 |
p. e451 |
artikel |
2 |
Botulinum toxin A: a short-term treatment option for base-of-thumb osteoarthritis?
|
Døssing, Anna |
|
|
4 |
7 |
p. e453-e454 |
artikel |
3 |
Christiaan Scott: beacon for paediatric rheumatology on the African continent
|
Morgan, Jules |
|
|
4 |
7 |
p. e467 |
artikel |
4 |
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
|
Wallwork, Rachel |
|
|
4 |
7 |
p. e462-e464 |
artikel |
5 |
Global access to biological disease-modifying drugs
|
McCormick, Rachel |
|
|
4 |
7 |
p. e465 |
artikel |
6 |
How long do revised and multiply revised hip replacements last? A retrospective observational study of the National Joint Registry
|
Deere, Kevin |
|
|
4 |
7 |
p. e468-e479 |
artikel |
7 |
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study
|
Clark, Kristina E N |
|
|
4 |
7 |
p. e507-e516 |
artikel |
8 |
Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT)
|
Nguyen, Christelle |
|
|
4 |
7 |
p. e480-e489 |
artikel |
9 |
Plasma protein correlates of skin severity in systemic sclerosis
|
Assassi, Shervin |
|
|
4 |
7 |
p. e457-e458 |
artikel |
10 |
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
|
Goulenok, Tiphaine |
|
|
4 |
7 |
p. e458-e461 |
artikel |
11 |
Racial and ethnic differences in COVID-19 outcomes: a call to action
|
Robinson, Philip C |
|
|
4 |
7 |
p. e455-e457 |
artikel |
12 |
Research in Brief
|
Thorley, Jennifer |
|
|
4 |
7 |
p. e466 |
artikel |
13 |
Research priority setting for paediatric rheumatology in the UK
|
Smith, Eve M D |
|
|
4 |
7 |
p. e517-e524 |
artikel |
14 |
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
|
MacKenna, Brian |
|
|
4 |
7 |
p. e490-e506 |
artikel |
15 |
The long and winding road of revision hip replacement
|
Collins, Jamie E |
|
|
4 |
7 |
p. e452-e453 |
artikel |